Zonegran
Eisai to enter Russia with epilepsy launch
June 27, 2012Sales and Marketing Eisai, Russia, Zonegran, emerging markets, epilepsy
Eisai is to enter the Russian market for the first time with the launch of epilepsy drug Zonegran. Entry into the …
Zonegran study could pave way for paediatric licence
September 2, 2011Research and Development, Sales and Marketing Eisai, Zonegran, epilepsy, research and development news
Eisai’s epilepsy drug Zonegran has been found more effective than placebo in children with the neurological condition who have seizures. …
Elan expects Zonegran marketing probe to cost it $206m
July 19, 2010Sales and Marketing Elan, Zonegran
Elan Corporation expects to pay $206.3 million to settle a US government investigation into the way it marketed its anti-epileptic …
Latest content
Ofichem acquires US drug substance CDMO Kinentia
October 14, 2026
Jager-van Dijk is new Arletta Pharma Solutions CEOÂ
October 13, 2026
Tridem begins phase Ib trial of Parkinson’s disease vaccine
October 13, 2026
